Novel, potent, selective, and metabolically stable stearoyl-CoA desaturase (SCD) inhibitors
摘要:
We identified a series of structurally novel SCD (Delta 9 desaturase) inhibitors via high-throughput screening and follow-up SAR studies. Modi. cation of the central bicyclic scaffold has proven key to our potency optimization effort. The most potent analog (8g) had IC(50) value of 50 pM in a HEPG2 SCD assay and has been shown to be metabolically stable and selective against Delta 5 and Delta 6 desaturases. (C) 2009 Elsevier Ltd. All rights reserved.
Novel, potent, selective, and metabolically stable stearoyl-CoA desaturase (SCD) inhibitors
摘要:
We identified a series of structurally novel SCD (Delta 9 desaturase) inhibitors via high-throughput screening and follow-up SAR studies. Modi. cation of the central bicyclic scaffold has proven key to our potency optimization effort. The most potent analog (8g) had IC(50) value of 50 pM in a HEPG2 SCD assay and has been shown to be metabolically stable and selective against Delta 5 and Delta 6 desaturases. (C) 2009 Elsevier Ltd. All rights reserved.
Novel, potent, selective, and metabolically stable stearoyl-CoA desaturase (SCD) inhibitors
作者:Dmitry O. Koltun、Eric Q. Parkhill、Natalya I. Vasilevich、Andrei I. Glushkov、Timur M. Zilbershtein、Alexei V. Ivanov、Andrew G. Cole、Ian Henderson、Nathan A. Zautke、Sandra A. Brunn、Nevena Mollova、Kwan Leung、Jeffrey W. Chisholm、Jeff Zablocki
DOI:10.1016/j.bmcl.2009.02.019
日期:2009.4
We identified a series of structurally novel SCD (Delta 9 desaturase) inhibitors via high-throughput screening and follow-up SAR studies. Modi. cation of the central bicyclic scaffold has proven key to our potency optimization effort. The most potent analog (8g) had IC(50) value of 50 pM in a HEPG2 SCD assay and has been shown to be metabolically stable and selective against Delta 5 and Delta 6 desaturases. (C) 2009 Elsevier Ltd. All rights reserved.